How should I evaluate and manage a woman with three clustered hyperpigmented cervical lesions, no inflammation, non‑friable tissue, and normal cervical mucus?

Evaluation and Management of Clustered Hyperpigmented Cervical Lesions

These clustered hyperpigmented cervical lesions most likely represent benign blue nevi and should be biopsied to establish a definitive histologic diagnosis and exclude the rare possibility of cervical melanoma.

Diagnostic Approach

Immediate Biopsy is Essential

• Any grossly visible pigmented cervical lesion requires tissue diagnosis, as it is impossible to reliably distinguish between benign and malignant causes on visual inspection alone 1.
• Biopsy should sample all three lesions or at least representative areas if they are clustered together 2.
• Request deeper levels on pathology specimens if initial sections are non-diagnostic, as some pigmented lesions may require deeper cuts for detection 2.

Most Likely Diagnosis

Blue Nevi (Most Common)

• Blue nevi account for approximately 81% of all grossly visible pigmented cervical lesions and have an incidence of 1.2% in women undergoing cervical examination 2.
• These lesions typically occur in white women (52% of cases) with a mean age of 47 years (range 31-64 years) 2.
• Blue nevi are located in the endocervix, measure 0.1-2 cm (mean 0.68 cm), and present as 1-3 lesions per cervix 2.
• The lesions are composed of melanocytic cells in the cervical stroma and follow a benign clinical course 2.

Alternative Benign Diagnoses

Other benign entities in the differential include:

• Melanotic macule (3% of pigmented lesions): characterized by hyperpigmentation of basal keratinocytes in the ectocervical squamous epithelium 2.
• Hemosiderin deposition from prior biopsy sites or hemorrhagic Nabothian cysts (6-9% combined) 2.
• Hemangioma or other vascular lesions (3%) 2.

Critical Exclusion: Cervical Melanoma

• While extremely rare, cervical melanoma must be excluded through histologic examination 2, 1.
• The benign appearance (non-friable tissue, no inflammation, normal mucus) is reassuring but does not eliminate the need for tissue diagnosis 3.
• Approximately 97% of grossly visible pigmented cervical lesions have a histologic correlate on biopsy 2.

Management Algorithm

1. Perform colposcopy-directed biopsy of the pigmented lesions immediately 2, 1.
2. Ensure adequate tissue sampling: Request that pathology perform deeper levels if initial sections show no diagnostic findings 2.
3. Specify clinical concern on the pathology requisition: note "pigmented cervical lesions" to alert the pathologist to evaluate for melanocytic proliferations 2.
4. If blue nevi are confirmed: No further treatment is required; these are benign lesions 2.
5. If melanoma is diagnosed: Refer urgently to gynecologic oncology for staging and treatment per NCCN guidelines 4.

Common Pitfalls to Avoid

• Do not assume benign appearance means benign histology: Visual inspection cannot reliably differentiate pigmented lesions 1.
• Do not delay biopsy: While most pigmented cervical lesions are benign, the rare malignant cases require prompt diagnosis 2.
• Do not accept superficial biopsy as definitive: Some melanocytic lesions require deeper tissue levels for identification 2.
• Do not confuse with routine cervical screening abnormalities: These pigmented lesions require direct biopsy regardless of cytology results 4.